Hangzhou Boya Biopharmaceutical Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Corporate

  • Latest Deal Amount
  • $1.51M

  • Investors
  • 2

Hangzhou Boya Biopharmaceutical General Information

Description

Developer of commercial-stage pharmaceutical products designed to advance treatments for immune-mediated diseases and cancer. The company offers integrated capabilities in antibody engineering, clinical development, and large-scale manufacturing, enabling healthcare providers and patients access to high-quality biologics and innovative therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 1602, North Building, Gongyuan Building, Lingyin Street
  • Xihu District
  • Hangzhou, Zhejiang 310000
  • China
+86 0755
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • Room 1602, North Building, Gongyuan Building, Lingyin Street
  • Xihu District
  • Hangzhou, Zhejiang 310000
  • China
+86 0755

Hangzhou Boya Biopharmaceutical Timeline

202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hangzhou Boya Biopharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Corporate 24-Apr-2025 $1.51M Completed Generating Revenue
1. Seed Round 07-Apr-2024 Completed Startup
To view Hangzhou Boya Biopharmaceutical’s complete valuation and funding history, request access »

Hangzhou Boya Biopharmaceutical Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jiangxi Synergy Pharmaceutical Corporation Minority
Thunderstorm Investment Growth/Expansion Minority
To view Hangzhou Boya Biopharmaceutical’s complete investors history, request access »

Hangzhou Boya Biopharmaceutical FAQs

  • When was Hangzhou Boya Biopharmaceutical founded?

    Hangzhou Boya Biopharmaceutical was founded in 2023.

  • Where is Hangzhou Boya Biopharmaceutical headquartered?

    Hangzhou Boya Biopharmaceutical is headquartered in Hangzhou, China.

  • What industry is Hangzhou Boya Biopharmaceutical in?

    Hangzhou Boya Biopharmaceutical’s primary industry is Pharmaceuticals.

  • Is Hangzhou Boya Biopharmaceutical a private or public company?

    Hangzhou Boya Biopharmaceutical is a Private company.

  • What is Hangzhou Boya Biopharmaceutical’s current revenue?

    The current revenue for Hangzhou Boya Biopharmaceutical is .

  • Who are Hangzhou Boya Biopharmaceutical’s investors?

    Jiangxi Synergy Pharmaceutical and Thunderstorm Investment have invested in Hangzhou Boya Biopharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process